GlobalData on MSN6d
Zai Lab and argenx announce NMPA approval for sBLA for VYVGART HytruloZai Lab and argenx have announced receipt of approval from the National Medical Products Administration (NMPA) of China for ...
While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...
News Medical on MSN6h
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patientsThe ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...
First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – ...
Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics Third Quarter 2024 Results Conference Call. Before we begin, we want to advise you that over the course of the call, including any ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical Products Administrat ...
The Malaysian Institute of Road Safety Research (MIROS) has released three new guidelines on electric vehicle safety at its ...
The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of health ...
The 2021 expanded child tax credit brought the child poverty rate in the U.S. to a historic low. But when Congress did not ...
To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after her daughter was born prematurely. She visited her daughter Janelle twice a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback